- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Cutler: Trump Administration's Attention Not on Value-Based Purchasing
The Trump administration’s healthcare priorities have mainly focused on replacing the Affordable Care Act or reforming Medicaid, leading to concerns that value-based purchasing efforts will be left in the dust, said David M. Cutler, PhD, of Harvard University.
The Trump administration’s healthcare priorities have mainly focused on replacing the Affordable Care Act (ACA) or reforming Medicaid, leading to concerns that value-based purchasing efforts will be left in the dust, said David M. Cutler, PhD, of Harvard University.
Transcript (slightly modified)
Do you think this country’s trajectory of moving to value-based care will be altered under the current administration?
The move towards value-based care is, of course, an extremely important one. I have not heard the Trump administration say what its philosophy is about this. I am worried on 2 counts. One is, many of the programs that the Obama administration had started are either being slowed down or being cancelled entirely, which I don’t think is good news. But second, I also think their attention is elsewhere, so their attention is on repealing the ACA, or what should be in a replacement bill, or on Medicaid and work requirements.
Their attention isn’t on value-based purchasing. That suggests to me that they’re not going to be actively thinking about it, and this is one of those topics that you kind of have to put the effort into doing, because it doesn’t happen on its own.
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
